Sustained Short-Selling Flow
ImmunityBio, Inc. (IBRX) has been flagged for sustained short-selling pressure, appearing on the FINRA Reg SHO threshold list for 49 consecutive trading days. This indicates that the stock has consistently met the criteria of having more than 50% of its daily trading volume marked as short, a strong indicator of persistent bearish flow.
Understanding the Signal
This signal is derived from daily FINRA Consolidated NMS short-volume files. Unlike official short interest, which is reported twice monthly, this threshold list data provides a near-real-time view of daily short-selling pressure. For IBRX, the 49-day duration suggests that the short-selling is not merely a temporary hedge but a sustained effort by market participants to pressure the stock price.
Key Takeaways
- IBRX has been on the Reg SHO threshold list for 49 days.
- The stock consistently exceeds the 50% daily short volume ratio.
- This signal highlights persistent daily bearish pressure.
- Investors should be aware of the potential for increased volatility and settlement-related risks.
The Bottom Line
IBRX is currently experiencing a prolonged period of intense short-selling pressure, as evidenced by its 49-day streak on the FINRA threshold list.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.